Delta Mutation: The first cases of the Delta variant in South Korea

The Korean Office of Disease Control and Prevention (KDCA) announced today that the first her first two cases Delta + variantof the new coronavirus, at the time that the South Korea finds it difficult to stop the so-called fourth wave of the pandemic.

Delta + is its subsidiary Delta mutation originally identified in India, with the noticeable difference that it has included in its genome the K417N spike protein, an element that has in common with the Beta variant, which was originally identified in South Africa, scientists explain.

Delta + cases are few internationally at this stage. Britain, Portugal and India have listed a few, among a few more countries.

40aris “without a history of recent trips” the first case

The first case found in South Korea is forty “without a history of recent trips”, KDCA clarified to the Reuters news agency and broadcasts AMPE. The secondly He was identified as “a person who had traveled abroad,” he added.

Health officials say many of the most widely used vaccines remain effective against the highly contagious Delta mutant, which has already become prevalent in several countries, but there are concerns that some strains of SARS-CoV-2 may overwhelm the antibodies. creating some of the vaccines.

The KDCA also reported that a total of 1,202 cases of SARS-CoV-2 were detected in the 24-hour period until midnight yesterday Monday, while five patients with COVID-19 succumbed. The pandemic toll thus reached 2,104 deaths out of a total of 202,203 infections.

To date, 20 million people, or 39% of South Korea’s population, have received at least one dose of one of the approved COVID-19 vaccines, and 14.1% have been fully vaccinated. Seoul aims to immunize at least 36 million South Koreans by September.